发明申请
US20090149376A1 Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction 有权
关于哮喘和可逆性支气管阻塞的9型腺苷酰环化酶多态性的药物和治疗应用

  • 专利标题: Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction
  • 专利标题(中): 关于哮喘和可逆性支气管阻塞的9型腺苷酰环化酶多态性的药物和治疗应用
  • 申请号: US11912205
    申请日: 2006-04-24
  • 公开(公告)号: US20090149376A1
    公开(公告)日: 2009-06-11
  • 发明人: Stephen B. Liggett
  • 申请人: Stephen B. Liggett
  • 国际申请: PCT/US06/15221 WO 20060424
  • 主分类号: A61K31/7088
  • IPC分类号: A61K31/7088 G01N33/53 C12Q1/68 A61P11/06
Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction
摘要:
A pharmaceutical composition comprising an expression product of a Type Nine adenylyl cyclase gene polymorphism, along with a suitable physiological carrier, are provided. In addition, methods related to treating patients having asthma or a reversible bronchial obstruction, kits for determining the responsiveness of an individual to treatment regimens, and assays for screening pharmaceutical for efficacy in treatment are also provided.
信息查询
0/0